CD4+ T cell activation and inflammation in NASH-related fibrosis
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Liver fibrosis is a common pathological feature of end stage liver failure, a severe life-threatening disease worldwide. Nonalcoholic fatty liver disease (NAFLD), especially its more severe form with steatohepatitis (NASH), results from obesity, type 2 diabetes and metabolic syndrome and becomes a leading cause of liver fibrosis. Genetic factor, lipid overload/toxicity, oxidative stress and inflammation have all been implicated in the development and progression of NASH. Both innate immune response and adaptive immunity contribute to NASH-associated inflammation. Innate immunity may cause inflammation and subsequently fibrosis via danger-associated molecular patterns. Increasing evidence indicates that T cell-mediated adaptive immunity also provokes inflammation and fibrosis in NASH via cytotoxicity, cytokines and other proinflammatory and profibrotic mediators. Recently, the single-cell transcriptome profiling has revealed that the populations of CD4+ T cells, CD8+ T cells, γδ T cells, and TEMs are expanded in the liver with NASH. The activation of T cells requires antigen presentation from professional antigen-presenting cells (APCs), including macrophages, dendritic cells, and B-cells. However, since hepatocytes express MHCII molecules and costimulators, they may also act as an atypical APC to promote T cell activation. Additionally, the phenotypic switch of hepatocytes to proinflammatory cells in NASH contributes to the development of inflammation. In this review, we focus on T cells and in particular CD4+ T cells and discuss the role of different subsets of CD4+ T cells including Th1, Th2, Th17, Th22, and Treg in NASH-related liver inflammation and fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114 · cited 1×
“Costimulatory molecules are present on the surface of T cells and APCs binding with each other in a paired ligand-receptor manner, which leads to the activation of these cells and thus triggers immune response (58).”
BackgroundResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084
Immune surveillance by the liver
Jenne, C. N., & Kubes, P. (2013) · Nature Immunology · doi:10.1038/ni.2691 · Cited by 1,047
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985 · cited 1×
“Hepatic DCs are mainly localized at the portal vein, with a minor presence at the central vein (35) and their numbers are markedly increased in NASH patients (36).”
Backgroundγδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Self-citation
Research works printed but not linked: 66
- Rinella, 2015, Nonalcoholic fatty liver disease: a systematic review, JAMA, 313, 10.1001/jama.2015.5370 · DOI · Paper page
- Cariou, 2021, Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review, Diabetes Obes Metab, 23, 10.1111/dom.14322 · DOI · Paper page
- Mishra, 2012, Epidemiology and natural history of non-alcoholic fatty liver disease, J Clin Exp Hepatol, 2, 10.1016/S0973-6883(12)60102-9 · DOI
- Estes, 2018, Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, united kingdom, and united state or the period 2016-2030, J Hepatol, 69, 896, 10.1016/j.jhep.2018.05.036 · DOI · Paper page
- Zhou, 2020, Epidemiological features of NAFLD from 1999 to 2018 in China, Hepatology, 71, 10.1002/hep.31150 · DOI · Paper page
- Lindenmeyer, 2018, The natural history of nonalcoholic fatty liver disease-an evolving view, Clin Liver Dis, 22, 11, 10.1016/j.cld.2017.08.003 · DOI · Paper page
- Noureddin, 2018, NASH leading cause of liver transplant in women: Updated analysis of indications for liver transplant and ethnic and gender variances, Am J Gastroenterol, 113, 10.1038/s41395-018-0088-6 · DOI · Paper page
- Chen, 2020, Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, Free Radic Biol Med, 152, 10.1016/j.freeradbiomed.2020.02.025 · DOI · Paper page
- Arroyave-Ospina, 2021, Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: Implications for prevention and therapy, Antioxidants (Basel), 10, 10.3390/antiox10020174 · DOI · Paper page
- Martinon, 2008, Detection of immune danger signals by NALP3, J Leukoc Biol, 83, 10.1189/jlb.0607362 · DOI · Paper page
- Cai, 2017, NLRP3 deletion inhibits the non-alcoholic steatohepatitis development and inflammation in kupffer cells induced by palmitic acid, Inflammation, 40, 10.1007/s10753-017-0628-z · DOI
- Gaul, 2021, Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis, J Hepatol, 74, 10.1016/j.jhep.2020.07.041 · DOI · Paper page
- Krenkel, 2017, Liver macrophages in tissue homeostasis and disease, Nat Rev Immunol, 17, 10.1038/nri.2017.11 · DOI · Paper page
- Krenkel, 2018, Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis, Hepatology, 67, 10.1002/hep.29544 · DOI · Paper page
- Kesar, 2014, Toll-like receptors and liver disease, Liver Int, 34, 10.1111/liv.12315 · DOI
- Petrasek, 2013, Toll-like receptors in liver disease, Adv Clin Chem, 59, 155, 10.1016/b978-0-12-405211-6.00006-1 · DOI
- Bieghs, 2014, Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease, Hepatobiliary Surg Nutr, 3, 10.3978/j.issn.2304-3881.2014.12.04 · doi:10.3978/j.issn.2304-3881.2014.12.04 · Paper page
- Pennington, 2005, The integration of conventional and unconventional T cells that characterizes cell-mediated responses, Adv Immunol, 87, 27, 10.1016/S0065-2776(05)87002-6 · DOI
- Godfrey, 2015, The burgeoning family of unconventional T cells, Nat Immunol, 16, 10.1038/ni.3298 · DOI · Paper page
- Haas, 2019, Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution, Nat Metab, 1, 10.1038/s42255-019-0076-1 · DOI · Paper page
- Yuseff, 2013, How b cells capture, process and present antigens: a crucial role for cell polarity, Nat Rev Immunol, 13, 10.1038/nri3469 · DOI · Paper page
- Fillatreau, 2018, B cells and their cytokine activities implications in human diseases, Clin Immunol, 186, 26, 10.1016/j.clim.2017.07.020 · DOI · Paper page
- Freitas-Lopes, 2017, Differential location and distribution of hepatic immune cells, Cells, 6, 10.3390/cells6040048 · DOI · Paper page
- Kambayashi, 2014, Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell, Nat Rev Immunol, 14, 10.1038/nri3754 · DOI · Paper page
- Zhou, 2021, MHC class II in renal tubules plays an essential role in renal fibrosis, Cell Mol Immunol, 18, 10.1038/s41423-021-00763-z · DOI
- Franco, 1988, Expression of class I and class II major histocompatibility complex antigens on human hepatocytes, Hepatology, 8, 10.1002/hep.1840080302 · DOI · Paper page
- Koch, 2010, Hypothesis: Targeted ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes, Hepat Med, 2010, 39, 10.2147/HMER.S7208 · DOI
- Dienes, 1987, Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis b and non-a, non-b, Hepatology, 7, 10.1002/hep.1840070623 · DOI
- Lu, 2020, Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH) and normal controls, Alcohol, 84, 27, 10.1016/j.alcohol.2019.08.008 · DOI
- Alcover, 2018, Cell biology of T cell receptor expression and regulation, Annu Rev Immunol, 36, 10.1146/annurev-immunol-042617-053429 · DOI · Paper page
- Shah, 2021, T Cell receptor (TCR) signaling in health and disease, Signal Transduct Target Ther, 6, 412, 10.1038/s41392-021-00823-w · DOI · Paper page
- Liang, 2020, The T cell receptor immune repertoire protects the liver from reconsitution, Front Immunol, 11, 10.3389/fimmu.2020.584979 · DOI · Paper page
- Goronzy, 2008, T-Cell co-stimulatory pathways in autoimmunity, Arthritis Res Ther, S3, 10.1186/ar2414 · DOI
- Boleto, 2018, Targeting costimulatory pathways in systemic sclerosis, Front Immunol, 9, 10.3389/fimmu.2018.02998 · DOI
- Webb, 2016, OX40, OX40L and autoimmunity: a comprehensive review, Clin Rev Allergy Immunol, 50, 10.1007/s12016-015-8498-3 · DOI · Paper page
- Sun, 2018, OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis, Cell Rep, 25, 3786, 10.1016/j.celrep.2018.12.006 · DOI · Paper page
- Publicover, 2018, An OX40/OX40L interaction directs successful immunity to hepatitis b virus, Sci Transl Med, 10, 10.1126/scitranslmed.aah5766 · DOI
- Heymann, 2016, Immunology in the liver–from homeostasis to disease, Nat Rev Gastroenterol Hepatol, 13, 88, 10.1038/nrgastro.2015.200 · DOI · Paper page
- Her, 2020, CD4 + T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice, Front Immunol, 11, 10.3389/fimmu.2020.580968 · DOI · Paper page
- Saigusa, 2020, T Cell subsets and functions in atherosclerosis, Nat Rev Cardiol, 17, 387, 10.1038/s41569-020-0352-5 · DOI · Paper page
- Ferreyra Solari, 2012, The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis, J Clin Immunol, 32, 10.1007/s10875-011-9635-2 · DOI · Paper page
- Shimamura, 2008, Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model, J Immunol, 181, 10.4049/jimmunol.181.7.4656 · DOI · Paper page
- Gao, 2016, IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis, Oncotarget, 7, 10.18632/oncotarget.9259 · DOI · Paper page
- Tan, 2013, IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation, J Immunol, 191, 10.4049/jimmunol.1203013 · DOI · Paper page
- Wang, 2014, Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Nature, 514, 10.1038/nature13564 · DOI · Paper page
- Yang, 2010, Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22, J Hepatol, 53, 10.1016/j.jhep.2010.03.004 · DOI · Paper page
- Zhu, 2008, CD4 T cells: fates, functions, and faults, Blood, 112, 10.1182/blood-2008-05-078154 · DOI · Paper page
- Zhang, 2017, 'Repair' treg cells in tissue injury, Cell Physiol Biochem, 43, 10.1159/000484295 · DOI · Paper page
- O'Garra, 2004, Development and function of T helper 1 cells, Adv Immunol, 83, 10.1016/S0065-2776(04)83004-9 · DOI
- Kremer, 2006, Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis, Hepatology, 10.1002/hep.21221 · DOI · Paper page
- Nakayama, 2017, Th2 cells in health and disease, Annu Rev Immunol, 35, 53, 10.1146/annurev-immunol-051116-052350 · DOI · Paper page
- Molina, 2019, Type 3 cytokines in liver fibrosis and liver cancer, Cytokine, 124, 154497, 10.1016/j.cyto.2018.07.028 · DOI
- Vonghia, 2015, CD4+ROR γ t++ and tregs in a mouse model of diet-induced nonalcoholic steatohepatitis, Mediators Inflammation, 2015, 10.1155/2015/239623 · DOI · Paper page
- He, 2017, The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice, BMC Immunol, 18, 33, 10.1186/s12865-017-0215-y · DOI
- Xu, 2013, Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice, Acta Biochim Biophys Sin (Shanghai), 45, 10.1093/abbs/gmt065 · DOI · Paper page
- Harley, 2014, IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice, Hepatology, 59, 10.1002/hep.26746 · DOI · Paper page
- Jiang, 2021, Role of Th22 cells in the pathogenesis of autoimmune diseases, Front Immunol, 12, 10.3389/fimmu.2021.688066 · DOI
- Jiang, 2011, Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3, Hepatology, 54, 10.1002/hep.24486 · DOI · Paper page
- Mangodt, 2015, The role of Th17 and treg responses in the pathogenesis of RSV infection, Pediatr Res, 78, 10.1038/pr.2015.143 · DOI
- Xu, 2017, PPAR-γ agonist ameliorates liver pathology accompanied by increasing regulatory b and T cells in high-fat-diet mice, Obes (Silver Spring), 25, 10.1002/oby.21769 · DOI
- Ma, 2007, A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury, Hepatology, 46, 10.1002/hep.21823 · DOI · Paper page
- Ilan, 2010, Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice, Proc Natl Acad Sci U.S.A., 107, 10.1073/pnas.0908771107 · DOI · Paper page
- Söderberg, 2011, Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis, APMIS, 119, 10.1111/j.1600-0463.2011.02746.x · DOI · Paper page
- Katz, 2011, Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis, J Immunol, 187, 10.4049/jimmunol.1004077 · DOI · Paper page
- Racanelli, 2006, The liver as an immunological organ, Hepatology, 43, 10.1002/hep.21060 · DOI · Paper page
- Wang, 2020, γδ T cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis, Hepatology, 71, 10.1002/hep.31025 · DOI
Cited by
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
The role of CXCL family members in different diseases
Zhou, C., Gao, Y., Ding, P., Wu, T., & Ji, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01524-9 · Cited by 286
Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice
Luo, S., Zhao, X., Jiang, J., Deng, B., Liu, S., Xu, H., Tan, Q., Chen, Y., Zhang, Z., Pan, X., et al. (2023) · Theranostics · doi:10.7150/thno.86103 · Cited by 76
“Besides macrophages, other immune cells, such as neutrophils [50], DCs [51], T cells [52-54], etc., participate in development of hepatic fibrosis partially by crosstalk with HSCs. Piezo1 plays a role on innate and adaptive immune response [19, 55].”
Self-citationSGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation
Liu, W., You, D., Lin, J., Zou, H., Zhang, L., Luo, S., Yuan, Y., Wang, Z., Qi, J., Wang, W., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.08.005 · Cited by 61
Self-citationBreaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-08-10
- Volume
- 13
- Pages
- 967410-967410
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4293778079
- Cited by
- 106
- References
- 45
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Natural Science Foundation of China (81970606, 81970595, 81970636, 81970642)
- Shenzhen Technical Project
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD4+ T cell activation and inflammation in NASH-related fibrosis. https://app.cochat.ai/papers/10.3389/fimmu.2022.967410
- The paper
- Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022). CD4+ T cell activation and inflammation in NASH-related fibrosis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.967410
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.